Author

M. W. Nasser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Approach:statistical model· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

S. K. Batra· 4 shared R. Chirravuri Venkata· 3 shared D. Doss· 2 shared I. Thapa· 2 shared N. Perumal· 2 shared S. Mahapatra· 2 shared A. K. Ganti· 1 shared A. Mohanty· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

S. K. Batra

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Repressing ABCB7 Potentiates Cisplatin Response in Pediatric Group 3 Medulloblastoma by Triggering Ferroptosis

R. K. Kanchan, N. Perumal, P. Khan, D. Doss, P. Gopalakrishnan, R. Chirravuri Venkata, I. Thapa, R. Vengoji, J. Kaushal, J. A. Siddiqui, M. W. Nasser, S. K. Batra, S. Mahapatra

This study shows that repressing ABCB7 in group 3 medulloblastoma triggers ferroptosis, enhancing cisplatin response and survival.

bioRxiv · Jan 24, 2022 · PreprintCancer Biology

MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB)

N. Perumal, R. Kanchan, D. Doss, N. Bastola, P. Atri, R. Chirravuri Venkata, I. Thapa, D. Klinkebiel, G. A. Talmon, M. W. Nasser, S. K. Batra, S. Mahapatra

This study identifies miR-212-3p as a tumor suppressor in group 3 medulloblastoma by targeting NFIB, reducing cancer cell proliferation and metastasis.

bioRxiv · Apr 15, 2021Cancer Biology

1q21.3 amplification modulates therapy sensitivity in Triple-Negative Breast Cancer

R. Chirravuri Venkata, D. Ghersi, A. K. Ganti, I. Lakshmanan, S. Chaudhary, S. K. Batra, M. W. Nasser

The paper identifies 1q21.3 amplification as a genetic marker linked to therapy sensitivity in Triple-Negative Breast Cancer.

bioRxiv · Apr 29, 2020 · PreprintCancer Biology

A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis

A. Mohanty, A. Nam, A. Pozhitkov, S. Bhattacharya, L. Yang, A. Nathan, X. Wu, S. Srivastava, I. Mambetsariev, M. Nelson, R. Pangeni, D. Raz, Y. Chen, Y. He, J. Orban, , R. Salgia

This study identifies a non-genetic mechanism for cisplatin resistance in lung adenocarcinoma involving the integrin β4/paxillin axis and its regulation of USP1 and VDAC1.

bioRxiv · Sep 25, 2019Cancer Biology